Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,356
datasets available to search
ShareScore release 0.9.0
Dataset results
10,356 results for “Severity”
Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02895100. IPD Sharing: UNDECIDED. Countries: 17. Publications: 1.
Ivermectin for Severe COVID-19 Management
ClinicalTrials.gov study NCT04646109. IPD Sharing: NO. Countries: 1. Publications: 5.
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT02201524. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)
ClinicalTrials.gov study NCT02293902. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation
ClinicalTrials.gov study NCT01386944. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.
ClinicalTrials.gov study NCT01838616. IPD Sharing: Not stated. Countries: 4. Publications: 1.
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT01885078. IPD Sharing: YES. Countries: 38. Publications: 9.
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT00535782. IPD Sharing: Not stated. Countries: 4. Publications: 1.
TXA127 for the Treatment of Severe COVID-19
ClinicalTrials.gov study NCT04401423. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine
ClinicalTrials.gov study NCT04353037. IPD Sharing: YES. Countries: 1. Publications: 17.
Association of Systemic Immune-inflammation Index and Severity of Diabetic Ketoacidosis in Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT06251895. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondyl
ClinicalTrials.gov study NCT03357471. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
ClinicalTrials.gov study NCT03720470. IPD Sharing: YES. Countries: 18. Publications: 10.
Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)
ClinicalTrials.gov study NCT01416636. IPD Sharing: Not stated. Countries: 4. Publications: 5.
Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01313221. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty
ClinicalTrials.gov study NCT02820324. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)
ClinicalTrials.gov study NCT00608777. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab
ClinicalTrials.gov study NCT02937701. IPD Sharing: Not stated. Countries: 9. Publications: 1.
A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms
ClinicalTrials.gov study NCT04430855. IPD Sharing: YES. Countries: 4. Publications: 0.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
ClinicalTrials.gov study NCT01621178. IPD Sharing: YES. Countries: 9. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.